74.Умнова М.А., Пискунова Т.М., Ичаловская Т.А. (Umnova M. A., Piskunova T. M., Ichalovskaya T.A.) Isosensitization to Kell, Cellano and Duffy Factors and the Distribution of theseFactorsamongthePopulation//Proc.9-thCongr.Int.Soc.BloodTransf.–Mexico,1962.– Karger.–1964.–Р.344–346.
75.Умнова М.А., Пискунова Т.М., Ичаловская Т.А. Сенсибилизация беременной фактором Келл и распределение этого фактора // Акушерство и гинекология. – 1963. – № 5. – С. 79–82.
76.Умнова М.А., Прокоп О., Пискунова Т.М. и др. Распределение различных факторов крови у населения Москвы // XII Междунар. конгр. антропол. этнограф. наук. – М., 1964. – 8 с.
77.Умнова М.А., Хорват А. Распределение групповых факторов Rh-Hr, MNSs, K-k и P у населения Венгрии // Вопр. антропологии. – 1965. – Вып. 20.– С. 135–137.
78.Хромова Е.А. Иммуносерологические особенности крови аборигенов Среднего Приобья: автореф. дис. … канд. мед. наук. – Тюмень, 2003. – 22 с.
79.Червяков В.И. Профилактика посттрансфузионных осложнений, обусловленных антигенами Kell и hr' (c): автореф. дис. … канд. мед наук. – М., 2000. – 29 с.
80.Чимиддуламын Шарав. Групповые свойства крови у монголов: автореф. дис. … канд. мед наук. – 1970. – 16 с.
81.Шереметьева В.А., Горшков В.А. Коряки Камчатки. Генетическая характеристика и формирование генофонда // Генетика – 1977. – Т. 12. – С. 1119.
82.Эрикссон А., Золотарева И.М., Козинцев А.Г. и др. Генетические исследования марийцев (черемисов): Новые исследования по антропологии марийцев. – М., 1979. – С. 7.
83.Эрикссон А., Франтс Р. Исследование групп крови у коми-зырян в СССР // Финноугорский сборник. – М., 1982. – С. 79.
84.Abramson N., Schur P.H. The IgG subclasses of red cells antibodies and relationship to monocyte binding // Blood. – 1972. – V. 40. – Р. 500.
85.Advani H., Zamor J., Judd W. J. et al. Inactivation of Kell blood group antigens by 2-aminoethylisothiouronium bromide // Brit. J. Haemat. – 1982. – V. 51. – Р. 107–115.
86.Allen F.H., Krabbe S.M.R., Corcoran P.A. A new phenotype (McLeod) in the Kell bloodgroup system // Vox Sang. – 1961. – V. 6. – Р. 555–560.
87.Allen F.H., Lewis S.J. Kp a (Penney), a new antigen in the Kell blood group system // Vox Sang. – 1957. – V. 2. – Р. 81–87.
88.Allen F.H., Lewis S.J., Fudenburg H. Studies of anti-Kp b, a new antibody in the Kell blood group system // Vox Sang. – 1958. – V. 3. – Р. 1–13.
89.Allen F.H., Rosenfield R.E. Notation for the Kell blood-group system // Transfusion. – 1961. – V. 1. – Р. 305–307.
90.Allen F.H., Warshaw A.L. Blood group sensitization. A comparison of antigens K1 (Kell) and c (hr') // Vox Sang. – 1962. – V. 7. – Р. 222.
91.Amara S.G., Kuhar M.J. Neurotransmitter transporters: recent progress // Ann. Rev. Neurosci. – 1993. – V. 16. – Р. 73–93.
92.Anderson R.R., Sosler S.D., Kovach J., DeChristopher P.J. Delayed hemolytic transfusion reaction due to anti-Js a in an alloimmunized patient with a sickle cell syndrome //Amer. J. Clin. Path. – 1997. – V. 108. – Р. 658–661.
93.Archer G.T., Cooke B.R., Mitchell K., Parry P. Hyper-immunisation des donneurs de sang pour la production def gamma-globulines anti-Rh(D) // Rev. Franc. Transfus. – 1969. – V. 12. – Р. 341.
94.Avent N.D., Martin P.G. Kell typing by allele-specific PCR (ASP) // Brit. J. Haemat. – 1996 – V. 93. – Р. 728–730.
95.Ballas S.K., Bator S.M., Aubuchon J.P. et al. Abnormal membrane physical properties of red cells in McLeod syndrome // Transfusion. – 1990. – V. 30. – Р. 722–727.
431
96.Bar Shany S., Ben Porath D., Levene C. et al. K22, a ‘new’ para-Kell antigen of high frequency // Vox Sang. – 1982. – V. 42. – Р. 87–90.
97.Barrasso C, Baldwin M.L., Drew H., Ness P.M. In vivo survival of K:18 red cells in a recipient withanti-K18//Transfusion.–1983.–V.23.–Р.258–259.
98.Barrasso C., Eska P., Grindon A.J. et al.Anti-k18: an antibody defining another highfrequency antigen related to the Kell blood group system // Vox Sang. – 1975. –
V.29. – Р. 124–127.
99.Beanie K.M., Heinz B., Korol S.et al.Anti-K12 in the serum of two brothers: inheritance of the K:–12phenotype//Rev.Franc.Transfus.Immunohemat.–1982.–V.25.–Р.611–618.
100.Beattie K.M., Shafer A.W., Sigmund K., Cisco S. Mass screening ofAmerican Black donors toidentifyhighincidenceantigen-negativebloods[Abstract]//19-thCongr.Int.Soc.Blood Transfus., 1986. – Р. 312.
101.Beck M.L., Marsh W.L., Pierce S.R. et al. Auto-anti-Kp b associated with weakened antigenicity in the Kell blood group system: a second example // Transfusion. – 1979. –
V.19. – Р. 197–202.
102.Belhacene N., Maulon L., Guerin S. et al. Differential expression of the Kell blood group and CD 10 antigens: two related membrane metallopeptidases during differentiation of K562 cells by phorbol ester and hemin // FASEB J. – 1998. – V. 12. – Р. 531–539.
103.Bertelson C.J., Pogo A.O., Chaudhuri A. et al. Localization of the McLeod locus (XK) within Xp21 by deletion analysis //Amer. J. Hum. Genet. – 1988. – V. 42. – Р. 703–711.
104.Blancher A., Reid M.E., Socha W.W. Cross-reactivity of antibodies to human and primate red cell antigens // Transfus. Med. Rev. – 2000. – V. 14. – Р. 161–179.
105.Bony V., Gane P., Bailly P., Cartron J.P. Time-course expression of polypeptides carrying blood group antigens during human erythroid differentiation // Brit. J. Haemat. – 1999. –
V.107. – Р. 263–274.
106.Bove J.R., Johnson M., Francis B.J. et al.Anti-K w defining a new antigenic determinant // ProgramAABB 18thAnn. Meeting. – Florida, 1965. – Р. 60.
107.Bowman J.M., Harman F.A., Manning C.R., Pollock J.M. Erythroblastosis fetalis produced by anti-k // Vox Sang. – 1989. – V. 56. – Р. 187–189 and Vox Sang. – 1990. –
V.58. – Р. 139.
108.Branch D. R., Gaidulis L., Lazar G. S. Human granulocytes lack red cell Kx antigen // Brit.
J.Haemat. – 1986. – V.62. – Р. 747–755.
109.BranchD.R.,MuenschH.A.,SySiokHanA.L.,PetzL.D.Disulfidebondsarearequirement for Kell and Cartwright (Yt a) blood group antigen integrity // Brit. J. Haemat. – 1983. –
V.54. – Р. 573–578
110.Branch D.R., Petz L.D. A new reagent (ZZAP) having multiple applications in immunohematology //Amer. J. Clin. Path. – 1982. – V. 7. – Р. 161–167.
111.Branch D.R., Sy Siok Han A.L., Petz L.D. Unmasking of Kx antigen by reduction of disulphide bonds on normal and McLeod red cells // Brit. J. Haemat. – 1985 – V. 59 – Р. 505–512.
112.Brendel W.L., Issitt P.D., Moore R.E. et al. Temporary reduction of red cell Kell system antigen expression and transient production of anti-Kp b in surgical patient // Biotest Bull. – 1985. – V. 2. – Р. 201–206.
113.Brown A., Berger R., Lasko D. et al. The Day phenotype: a ‚new‘ variant in the Kell blood group system // Rev. Franc. Transfus. Immunohemat. – 1982. – V. 25 – Р. 619–627.
114.Brzica S.M., Rhodes K.H., Pineda A.A., Taswell H.E. Chronic granulomatous disease and the McLeod phenotype: successful treatment of infection with granulocyte transfusions resulting in subsequent hemolytic transfusion reaction // Mayo Clin. Proc. – 1977. –
V.52. – P. –153.
115.Byrne P.C., Deck M., Qyen R. et al. Serological and biochemical studies on a previously undescribed Kmod individual [Abstract] // Transfusion. – 1993. – V. 33 (Suppl.). – Р. 55S.
432
116.Caine M.E., Mueller-Heubach E. Kell sensitization in pregnancy // Amer. J. Obstet. Gynec. – 1986. – V. 154. – Р. 85–90.
117.Callender S., Race R.R. A serological and genetical study of multiple antibodies formed in response to blood transfusion by a patient with lupus erythematosus diffuses // Ann. Eugen. – 1946. – V. 13. – Р. 102–117.
118.Callender S., Race R.R., Paykoc Z.V. Hypersensitivity to transfused blood // Brit. Med.
J.– 1945. – ii. – Р. 83.
119.Camara-Clayette V., Rahuel C., Lopez C. et al. Transcriptional regulation of the KEL gene and Kell protein expression in erythroid and non-erythroid cells // Biochem. J. – 2001. – V. 356. – Р. 171–180.
120.CarbonnetF.,HattabC.,CallebautI.etal.Kx,aquantitativelyminorproteinfromhuman erythrocytes, is palmitoylated in vivo // Biochem. Biophys. Res. Commun. – 1998. –
V.250. – Р. 569–574.
121.Carbonnet F., Hattab C., Cartron J. P., Bertrand O. Kell and Kx, two disulphide-linked proteins of the human erythrocyte membrane are phosphorylated in vivo // Biochem. Biophys. Res. Commun. – 1998. – V. 247. – Р. 569–575.
122.Carbonnet F., Hattab C., Collec E. et al. Immunochemi-cal analysis of the Kx protein from humanredcellsofdifferentKellphenotypesusingantibodiesraisedagainstsyntheticpeptides// Brit.J.Haemat.–1997.–V. 96.– Р. 857–863.
123.CarstairsK.,RuthledgeHardingS.,LueK.etal.Anti-K9inanuntransfusedMcLeodindividual [Abstract]//Transfusion.–1988.–V. 28(Suppl.).–Р. 20S.
124.ChesterM.A.,JohnsonU.,LundbladA.etal.Proceedingsofthe2-ndInternationalWorkshop on MonoclonalAntibodiesAgainst Human Red Blood Cell and RelatedAntigens., 1990. –
P.126–138.
125.Chown B., Lewis M., Kaita H. A ‘new’ Kell blood-group phenotype // Nature. – Lond., 1957. – V. 180. – Р. 711.
126.ChownB.,LewisM.,KaitaH.etal.Thepedigreesoftwopeoplealreadyreportedasofphenotype K −,k −,Kp(a −b −)//VoxSang.–1961.–V. 6.– Р. 620–623.
127.Chown B., Lewis M., Kaita H., Philipps S. Some blood group frequencies in a Caucasian population//VoxSang.–1963.–V. 8.– Р. 378–381.
128.Chu T.H., Yazdanbakhsh K., Qyen R. et al. Production and characterization of anti-Kell, monoclonal antibodies using transfected cells, as the immunogen // Brit. J. Haemat. – 1999. – V. 106. – Р. 817–823.
129.Claperon A., Rose C., Gane P. et al. . The Kell protein of the common K2 phenotype is a catalytically active metalloprotease, whereas the rare Kell K1 antigen is inactive. Identification of novel substrates for the Kell protein // J. Biol. Chem. – 2005. – V. 280. – N 22. – Р. 21272–21283.
130.Clark A., Monaghan W.P., Martin C.A. Two additional examples of non-transfusion-stimulated anti-Kell//Amer.J.Med.Tech.–1981.–V. 47.–Р. 983–984.
131.CollecE.,ColinY.,CarbonnetF.etal.Structureandexpressionofthemousehomologueofthe XKgene//Immunogenetics.–1999.–V. 50.–Р. 16–21.
132.CoombsR.R.,MourantA.E.,RaceR.R.Detectionofweakand«incomplete»Rhagglutinins: a new test // Lancet. – 1945. – V. 2. – Р. 15.
133.Coombs R.R., Mourant A.E., Race R.R. In-vivo isosensitization of red cells in babies with haemolytic disease // Lancet. – 1946. – i. – Р. 264–266.
134.Corcoran P.A., Allen F.H., Lewis M., Chown B.Anew antibody, anti-Ku (anti-Peltz), in the Kell blood group system // Transfusion. – 1961. – V. 1. – Р. 181–183.
135.Costamagna L., Barbarini M., Viarengo G.L. et al. A case of hemolytic disease of the newborn due to anti-Kp a // Immunohematology. – 1997. – V. 13. – Р. 61–62.
136.CroucherB.E.Differentialdiagnosisofdelayedtransfusionreaction//AABB:Aseminaron laboratory management of hemolysis., 1979.
433
137.CurnutteJ.,BemillerL.ChronicgranulomatousdiseasewithMcLeodphenotype:anuncommon occurrence[Abstract]//Transfusion.–1995. – V. 35(Suppl.).– Р. 60S.
138.Dacus J.V., Spinnato J.A. Severe erythroblastosis fetalis secondary to anti-Kp b sensitization // Amer.J.Obstet.Gynec.–1984. – V. 150.–Р. 888–889.
139.DanekA.,RubioJ.P.,RampoldiL.etal.McLeodneuroacanthocytosis:genotypeandphenotype
//Ann.Neurol.–2001. – V. 50.–Р. 755–764.
140.Daniels G.L. Blood group antigens of high frequency: a serological and genetical study: PhD thesis.–UniversityofLondon,1980.
141.DanielsG.L.KellandKxbloodgroupsystems:HumanBloodGroups.–2-nded.–Oxford: Blackwell Science, 2002. – Р. 295–323.
142.DanielsG.L.Kellrelatedantibodies//RevFrancTransfusImmunohemat.–1988.–V.31.– Р. 395–405.
143.Daniels G.L., Anstee D.J., Cartron J.P. et al. Terminology for red cell surface antigens – Makuhari report // Vox Sang. – 1996. – V. 71. – Р. 246–248.
144.Daniels G.L., ed. Third International Workshop on Monoclonal Antibodies Against Human Red Blood Cell and Related Antigens // Transfus. Clin. Biol. – 1997. – V. 4. – Р. 99–114.
145.Daniels G.L., Green C. Expression of red cell surface antigens during erythropoiesis // Vox Sang.–2000. – V. 78(Suppl.1).–Р. 149–153.
146.Daniels G.L., Hadley A.G., Green C.A. Fetal anaemia due to anti-K may result from immune destruction of early erythroid progenitors [Abstract] // Transfus. Med. – 1999. – V. 9 (Suppl.). – Р. 16.
147.Daniels G.L., Moulds J.J.,AnsteeD.J. et al. ISBTworking party on terminology for red cell surface antigens // Vox Sang. – 1993. – V. 65. – Р.77–80.
148.Daniels G.L., PettyA.C., Reid M. et al. Demonstration by the monoclonal antibody-specific immobilization of erythrocyte antigens assay that a new red cell antigen belongs to the Kell blood group system // Transfusion. – 1994. – V. 34. – Р. 818–820.
149.DanielsG.L.,ShawM.A.,JudsonP.A.etal.AfamilydemonstratinginheritanceoftheLeach phenotype: a Gerbich-negative phenotype associated with elliptocytosis // Vox Sang. – 1986. – V. 50. – Р. 117–121.
150.Daniels G.L., Weinauer F., Stone C. et al.Acombination of effects of rare genotypes at the XK and KELblood group loci results in absence of Kell system antigens from the red blood cells // Blood. – 1996. – V. 88. – P. 4045–4050.
151.Darnborough J., Dunsford I. Неопубликованное сообщение, 1959. Цит. по Race R. R., Sanger R. Blood Groups in Man. – 6-th ed. –Oxford: BSP, 1975. – Р. 303.
152.De Saint-Basile G., Bohler M.C., Fischer A. et al. Xp21 DNA microdeletion in a patient with chronic granulomatous disease, retinitis pigmentosa, and McLeod phenotype // Hum. Genet. – 1988. – V. 80. – Р. 85–89.
153.DerringtonM.M.,SoothillJ.F.Animmunochemicalstudyoftheproteinsoftheamnioticfluid and of maternal and foetal serum // J. Obstet. Gynaec. Brit. Cwlth. – 1961. –V. 68. – Р. 755.
154.Dichupa P.J.,Anderson C., Chown B.Afurther search for hypothetic K pof the Kell-system
//Vox Sang. – 1969. – V. 17. – Р. 1–4.
155.Dinning G., Doughty R.W., Collins A.K.Afurther example of IgM anti-K2 (Cellano) // Vox Sang. – 1985. – V. 48. – Р. 317–318.
156.Doelman C.J., Westermann W.E., van Voorst tot Voorst E., Miedema K. An anti-K apparently inducedbyEnterococcusfaecalisina30-year-oldman//Transfusion.–1992.–V.32.–Р.790.
157.DonovanL..,TrippK.L.,ZuckermanJ.E.,KonugresA.A.Hemolyticdiseaseofthenewborn due to anti-Js a // Transfusion. – 1973. – V. 13. – Р. 153.
158.Dotti M. T., Battisti C., Malandrini A. et al. McLeod syndrome and neuroacanthocytosis with a novel mutation in the XK gene // Mot Disord. – 2000. – V. 15. – Р. 1282–1285.
434
159.Eby C.S., Cowan J.L., Ramos R.R., Chaplin H. In-vivo and in-vitro studies of anti-Kp b allo-antibody [Abstract] // Joint Congr. Int. Soc. Blood. Transfus. and Amer. Assoc. Blood Banks. – 1990. – P. 156.
160.Eicher C., Kirkley K., Porter M., Kao Y. A new low frequency antigen in the Kell system: K24 // Transfusion. – 1985. – V. 27. – P. 36–40.
161.El Nemer W., Colin Y., Collec E. et al. Analysis of deletions in three McLeod patients: exclusionoftheXSlocusfromtheXp21.1-Xp21.2region//Eur.J.Immunogenet.–2000.–
V.27. – Р. 29–33.
162.Eveland D. Autoanti-Js b enhanced by polyethylene glycol [Abstract] // Joint. Congr. Int. Soc. BloodTransfus.andAmer.Assoc.BloodBanks,1990.–P.156.
163.FikrigS.M.,PhillippJ.C.D.,SmithwickE.M.etal.ChronicgranulomatousdiseaseandMcLeod syndromeinaBlackchild//Pediatrics.–1980. – V. 66.– P. 403–404.
164.Ford D.S., Knight A.E., Smith F. A further example of Kp a / K° exhibiting depression of some Kellgroupantigens//VoxSang.–1977. – V. 32.– P. 220–223.
165.Francke U., Ochs H.D., de Martinville B. et al. Minor Xp21 chromosome deletion in a male associated with expression of Duchenne muscular dystrophy, chronic granulomatous disease, retinitis pigmentosa, and McLeod syndrome // Amer. J. Hum. Genet. – 1985. –
V.37. – P. 250–267.
166.Frank S., Schmidt R.P., Baugh M. Three new antibodies to high-incidence antigenic determinants (anti-El, anti-Dp, and anti-So) // Transfusion. – 1970. – V. 10. – P. 254–257.
167.Frey D., Machler M., Seger R. et al. Gene deletion in a patient with chronic granulomatous disease and McLeod syndrome: fine mapping of the Xk gene locus // Blood. – 1988. –
V.71. – P. 252–255.
168.Furuhjelm U., Nevanlinna H.R., Nurkka R. et al. Evidence that the antigen Ul a is controlled from the Kell complex locus // Vox Sang. – 1969. – V. 16. – P. 496–499.
169.Furuhjelm U., Nevanlinna H.R., Nurkka R. et al. The blood group antigen Ul a (Karhula) // Vox Sang. – 1968. – V. 15. – P. 118–124.
170.Galey W. R., Evan A. P., Van Nice P. S. et al. Morphology and physiology of the McLeod erythrocyte. I. Scanning electron microscopy and electrolyte and water transport properties // Vox Sang. – 1978. – V. 34. – P. 152–161.
171.Garratty G., Sattler M.S., Petz L.D., Flannery E.P. Immune hemolytic anemia associated with anti-Kell and a carrier state for chronic granulomatous disease // Rev. Franc. Transfus. Immunohemat. – 1979. – V. 22. – P. 529–549.
172.Garretta M., Gener J., Muller A. Analyse de 280000 determinations du facteur Kell sur les equipements Groupamatic // Rev. Franc. Transfus. Immunohemat. – 1978. – V. 2. –
P.379–386.
173.Gavin J., Daniels G.L., Yamaguchi H. et al. The red cell antigen once called Levay is the antigen Kp c of the Kell system // Vox Sang. – 1979. – V. 36. – P. 31–33.
174.Giblett E.R. A critique of the thoretical hazard of inter vs. intra-racial transfusion // Transfusion. – 1961. – V. 1. – P. 233–238.
175.Giblett E.R. Js, a ‘new’blood group antigen found in Negroes // Nature. – 1958. – V. 181. –
P.1221–1222.
176.GiblettE.R.,ChaseJ.Js a a‘new’redcellantigenfoundinNegroes;evidenceforaneleventh blood group system // Brit. J. Haemat. – 1959. – V. 5. – P. 319–326.
177.Giblett E.R., Klebanoff S. J., Pincus S.H. et al. Kell phenotypes in chronic granulomatous disease: a potential transfusion hazard // Lancet. – 1971. – i. – P. 1235–1236.
178.Glaubensklee C.S., Evan A.P., Galey W.R. Structural and biochemical analysis of the McLeod erythrocyte membrane. I. Freeze fracture and discontinuous polyacrylamide gel electrophoresis analysis // Vox Sang. – 1982. – V. 42. – P. 262–271.
435